Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC01318, or Long intergenic non-protein coding RNA 1318, is a human gene that produces a long intergenic non-coding RNA transcript and does not encode a protein[1][5]. It is part of the large family of lincRNAs, which are generally longer than 200 nucleotides, lack significant protein-coding capacity, and are transcribed from regions not overlapping known protein-coding genes[5]. While the functions of most lincRNAs, including LINC01318, remain unclear, the class is thought to regulate gene expression at multiple levels, such as chromatin modification, transcription, or post-transcriptional processing[3][5]. LincRNAs have been implicated in diverse biological processes and diseases, and they are emerging as potential molecular biomarkers, but there is no specific evidence or data currently linking LINC01318 itself to therapeutic targeting, drug interaction, or a clear role as a disease biomarker[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1318 (LINC01318).